Literature DB >> 6192435

Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.

S J Korsmeyer, W C Greene, J Cossman, S M Hsu, J P Jensen, L M Neckers, S L Marshall, A Bakhshi, J M Depper, W J Leonard, E S Jaffe, T A Waldmann.   

Abstract

The origin and exact stage of differentiation of the neoplastic cells that comprise hairy cell leukemia have remained uncertain. As Ig heavy and light chain genes must both undergo a DNA rearrangement during B-cell development but rarely do so within other hematopoietic lineages, we examined these genes in this leukemia. The neoplastic cells of all eight cases demonstrated rearranged heavy and light chain genes and, in two cases examined, contained the corresponding mRNA for heavy and light chain Ig. Consistent with this B-cell genotype, all cases displayed cell surface HLA-DR and B-cell-associated antigens. Unexpectedly, all cases demonstrated cell surface Tac antigen, which previously had been restricted predominantly to select T-cell malignancies and activated T cells. Prior studies suggested that the anti-Tac monoclonal antibody recognized a peptide associated with the binding of interleukin 2 (T-cell growth factor) in such T cells. Immunoprecipitation with anti-Tac and NaDodSO4/polyacrylamide gel electrophoresis revealed an antigen on leukemic hairy cells with a Mr of 53,000-57,000, identical in size to the receptor on activated T cells. This apparent biphenotypic status might reflect a transformation-associated expression of the Tac antigen in this leukemia. Alternatively, hairy cell leukemia may be a malignancy of a unique stage of normal B-cell differentiation in which the Tac antigen is expressed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192435      PMCID: PMC384071          DOI: 10.1073/pnas.80.14.4522

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Sequences at the somatic recombination sites of immunoglobulin light-chain genes.

Authors:  H Sakano; K Hüppi; G Heinrich; S Tonegawa
Journal:  Nature       Date:  1979-07-26       Impact factor: 49.962

2.  Multiple heavy chain isotypes on the surface of the cells of hairy cell leukemia.

Authors:  G F Burns; J C Cawley; C P Worman; A Karpas; C R Barker; A H Goldstone; F G Hayhoe
Journal:  Blood       Date:  1978-12       Impact factor: 22.113

3.  Hairy cell leukemia: cellular characteristics including surface immunoglobulin dynamics and biosynthesis.

Authors:  H J Cohen; E R George; W B Kremer
Journal:  Blood       Date:  1979-04       Impact factor: 22.113

Review 4.  Hairy-cell leukaemia and prolymphocytic leukaemia.

Authors:  D Catovsky
Journal:  Clin Haematol       Date:  1977-02

5.  Leukemic reticuloendotheliosis: presence of a receptor for cytophilic antibody.

Authors:  E S Jaffe; E M Shevach; M M Frank; I Green
Journal:  Am J Med       Date:  1974-07       Impact factor: 4.965

6.  Hairy-cell leukemia with T-cell features.

Authors:  J C Cawley; G F Burns; T A Nash; K E Higgy; J A Child; B E Roberts
Journal:  Blood       Date:  1978-01       Impact factor: 22.113

7.  T-lymphocyte variant of hairy-cell leukemia.

Authors:  A Saxon; R H Stevens; D W Golde
Journal:  Ann Intern Med       Date:  1978-03       Impact factor: 25.391

Review 8.  Leukemic reticuloendotheliosis (hairy cell leukemia).

Authors:  B A Bouroncle
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

9.  Hairy cell leukemia: a clinical review based on 71 cases.

Authors:  H M Golomb; D Catovsky; D W Golde
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

10.  Immunoglobulin synthesis in hairy cell leukaemia.

Authors:  D W Golde; R H Stevens; S G Quan; A Saxon
Journal:  Br J Haematol       Date:  1977-03       Impact factor: 6.998

View more
  50 in total

1.  Hairy cell leukemia: 1986.

Authors:  D Catovsky
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-22

2.  The detection of Epstein-Barr virus in hairy cell leukemia cells by in situ hybridization.

Authors:  B C Wolf; A W Martin; R S Neiman; A J Janckila; L T Yam; A Caracansi; B A Leav; R Winpenny; D S Schultz; H J Wolfe
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

3.  Interferons regulate the in vitro differentiation of multilineage lympho-myeloid stem cells in hairy cell leukemia.

Authors:  R Michalevicz; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  [Therapeutic procedure in hairy cell leukemia].

Authors:  P von Wussow
Journal:  Klin Wochenschr       Date:  1987-07-15

5.  Longitudinal survey in an endemic region of plasma soluble interleukin-2 receptor and antibody levels in Plasmodium falciparum malaria.

Authors:  B F Chumpitazi; F Peyron; J Simon; C Boudin; I Sheick-Zakiuddin; S Picot; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

6.  Intracytoplasmic inclusions in B prolymphocytic leukaemia: ultrastructural, cytochemical, and immunological studies.

Authors:  D S Robinson; J V Melo; C Andrews; S A Schey; D Catovsky
Journal:  J Clin Pathol       Date:  1985-08       Impact factor: 3.411

7.  Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation.

Authors:  R J Armitage; J C Cawley
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

8.  Expression of Tac antigen in B cell lymphomas.

Authors:  G Laurent; T Al Saati; D Olive; J C Laurent; P Poncelet; G Delsol
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

9.  Constitutively activated Rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells.

Authors:  Xian Zhang; Takashi Machii; Itaru Matsumura; Sachiko Ezoe; Akira Kawasaki; Hirokazu Tanaka; Shuji Ueda; Hiroyuki Sugahara; Hirohiko Shibayama; Masao Mizuki; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

10.  Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis.

Authors:  K Nakanishi; T R Malek; K A Smith; T Hamaoka; E M Shevach; W E Paul
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.